+

US20030181749A1 - Supercritical fluid extraction of vitreoretinal silicone tamponades - Google Patents

Supercritical fluid extraction of vitreoretinal silicone tamponades Download PDF

Info

Publication number
US20030181749A1
US20030181749A1 US10/165,834 US16583402A US2003181749A1 US 20030181749 A1 US20030181749 A1 US 20030181749A1 US 16583402 A US16583402 A US 16583402A US 2003181749 A1 US2003181749 A1 US 2003181749A1
Authority
US
United States
Prior art keywords
carbon dioxide
approximately
fluid
silicone oil
extraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/165,834
Inventor
Jay Kunzler
Joseph Salamone
Dharmendra Jani
Erik Indra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/165,834 priority Critical patent/US20030181749A1/en
Assigned to BAUSCH & LOMB INCORPORATED reassignment BAUSCH & LOMB INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INDRA, ERIK M., JANI, DHARMENDRA, KUNZLER, JAY E., SALAMONE, JOSEPH C.
Priority to DE60323471T priority patent/DE60323471D1/en
Priority to ES03714340T priority patent/ES2312759T3/en
Priority to AU2003218343A priority patent/AU2003218343A1/en
Priority to PCT/US2003/008902 priority patent/WO2003080713A1/en
Priority to EP03714340A priority patent/EP1487903B1/en
Priority to ARP030100992 priority patent/AR039095A1/en
Publication of US20030181749A1 publication Critical patent/US20030181749A1/en
Priority to US10/801,741 priority patent/US7276619B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0834Compounds having one or more O-Si linkage
    • C07F7/0838Compounds with one or more Si-O-Si sequences
    • C07F7/0872Preparation and treatment thereof
    • C07F7/089Treatments not covered by a preceding group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/20Purification, separation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/32Post-polymerisation treatment
    • C08G77/34Purification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Definitions

  • the present invention relates to a novel, highly effective method to purify vitreofluid silicone oils or fluids using supercritical fluid extraction. More particularly, the present invention relates to a method for purifying vitreofluid silicone oils or fluids that is contaminant-free and, in most cases, does not require the disposal of organic solvents.
  • Ocular tamponades are vitreous substitutes that are used to reposition the retina of an eye in instances where a reattachment is not achievable by natural healing or by laser coagulation.
  • the purpose of a vitreous substitute is to provide long-term tamponade of the retina, i.e., exhibit an ideal pressure (force/area) to position and maintain the retina in place.
  • Current commercially used tamponades include perfluorocarbon-liquids, balanced salt solutions, silicone oil or fluid and gases, such as air, sulfur hexafluoride (SF 6 ) and perfluorocarbons (PFCs). Silicone oil or fluid is the preferred tamponade in cases of severe retina detachment, where the tamponade is used six months or longer.
  • Silicone oil or fluid is prepared by a ring-opening polymerization of strained cyclic silicones.
  • the final product consists of relatively high molecular weight silicone fluid and unreacted relatively low molecular weight cyclic siloxanes and oligomers.
  • the unreacted relatively low molecular weight cyclics and oligomers are cytotoxic and have been implicated in an undesirable emulsification phenomenon that sometimes occurs in silicone-based fluids. Accordingly, the unreacted relatively low molecular weight cyclics and oligomers must be removed from the silicone fluid product to be useful as an ocular tamponade.
  • the preferred current method of purifying relatively high molecular weight silicone oil, or silicone fluid involves the use of a lengthy solvent extraction process whereby the silicone fluid is slowly added to a non-solvent, such as acetone, and allowed to separate.
  • a non-solvent such as acetone
  • the unreacted low molecular weight cyclics and oligomers are soluble in the non-solvent or acetone phase.
  • the unreacted low molecular weight cyclics and oligomers are thus removed with the non-solvent or acetone phase upon separation thereof from the high molecular weight silicone fluid.
  • the non-solvent phase with the low molecular weight cyclics and oligomers becomes an undesirable waste product of the purification method and requires disposal.
  • controls are necessary to ensure the final silicone oil or fluid product is free of non-solvent contamination.
  • the present invention is an economical, highly effective process for the purification of relatively high molecular weight vitreofluid silicone oils or fluids using carbon dioxide supercritical fluid (SCF) extraction.
  • a fluid with its temperature and pressure simultaneously higher than its critical temperature and pressure is in the supercritical state.
  • SCF supercritical fluid
  • carbon dioxide is a gas at ambient conditions. In a supercritical state, it is essentially a compressed, high density fluid.
  • Carbon dioxide is relatively innocuous, economical, and non-reactive under most operating conditions.
  • the density, solvent power or selectivity of a SCF is easily altered with relatively small changes in pressure or by addition of small amounts of an organic solvent. The change in carbon dioxide density with pressure at 35 degrees Celsius does not increase linearly with increasing pressure.
  • Another object of the present invention is to provide a process for the purification of relatively high molecular weight silicone fluid that is economical.
  • Another object of the present invention is to provide a process for the purification of relatively high molecular weight silicone fluid that is reproducible.
  • Another object of the present invention is to provide a process for the purification of relatively high molecular weight silicone fluid that is contaminant-free.
  • Another object of the present invention is to provide a process for the purification of relatively high molecular weight silicone fluid for use as an ocular tamponade.
  • Still another object of the present invention is to provide a process for the purification of a relatively high molecular weight silicone fluid that lessens or eliminates the need for non-solvent waste disposal.
  • a further object of the present invention is to eliminate low molecular weight silicone oligomers and cyclics from relatively high molecular weight silicone fluid in order to lessen or eliminate emulsification of the relatively high molecular weight silicone fluid in ocular tamponade uses.
  • the present invention relates to a novel process for the purification of relatively high molecular weight silicone oil or fluid for use as an ocular tamponade.
  • the purification process of the present invention is a novel, economical, highly effective, reproducible, contaminant-free process for removing relatively low molecular weight cyclics and oligomers from relatively high molecular weight silicone oil or fluid.
  • the subject process utilizes supercritical carbon dioxide (scCO 2 ) fluid extraction to purify silicone fluid for use as an ocular tamponade.
  • the supercritical carbon dioxide fluid has solvating powers comparable to those of organic solvents.
  • the solvating power of the supercritical carbon dioxide fluid is adjustable through variations in pressure and temperature, or by adding modifiers to form a mixture as discussed in more detail below.
  • suitable modifiers include but are not limited to methanol, isopropanol, acetonitrile and acetone.
  • a 5,000 cps silicone oil tamponade was purified using supercritical carbon dioxide fluid extraction.
  • the conditions of the supercritical carbon dioxide fluid extraction consisted of carbon dioxide at a pressure of approximately 3,000 pounds per square inch (psi), a temperature of approximately 55 degrees Celsius and a flow rate of approximately 52 gm per minute.
  • the relatively low molecular weight cyclics and oligomers were removed from the silicone fluid to a level below size exclusion chromatography (SEC) detection limits. More particularly, SEC showed the removal of relatively low molecular weight cyclics and oligomers with no change in the silicone fluid peak height. Similar results were obtained by extracting with supercritical carbon dioxide fluid containing 10 percent acetone.
  • Polydimethylsiloxane (21.01 gm) sample was loaded into a 0.7 inch tube. The loaded tube was then placed in a 3.0 inch cup. The 3.0 inch cup with the sample was placed into an extraction vessel and a lid with a 1 ⁇ 4 inch pipe attachment was placed on the extraction vessel. The lid was placed such that the 1 ⁇ 4 inch pipe attachment was inside the 0.7 inch tube.
  • the extraction vessel was then pressurized to 140 bar with carbon dioxide using bottom to top flow. The extraction vessel temperature was approximately 55 degrees Celsius in an oil bath of approximately 102 degrees Celsius. A flow of 26 gm per minute carbon dioxide was begun in the extraction vessel from the top to the bottom. After one hour and 37 minutes, an increased flow rate of 52 gm per minute carbon dioxide was begun.
  • Polydimethylsiloxane (21.01 gm) sample was loaded into a 0.7 inch tube. The loaded tube was then placed in a 3.0 inch cup. The 3.0 inch cup with the sample was then placed in an extraction vessel and a lid with a 1 ⁇ 4 inch pipe attachment was placed on the extraction vessel. The lid was placed such that the 1 ⁇ 4 inch pipe attachment was inside the 0.7 inch tube. The extraction vessel was then pressurized to 140 bar with carbon dioxide using bottom to top flow. The extraction vessel temperature was approximately 55 degrees Celsius in an oil bath of approximately 102 degrees Celsius. A flow of 6 gm per minute acetone and 20 gm per minute carbon dioxide was begun in the extraction vessel from the top to the bottom.
  • Silicone oil or fluid ocular tamponades purified using the purification process of the present invention are used as customary in the field of ophthalmology.
  • the silicone oil or fluid ocular tamponade purified in accordance with the process of the present invention is placed and maintained in the posterior segment of the eye for the desired period of time prior to the removal thereof.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Silicon Polymers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)

Abstract

A process for the purification of a silicone oil or fluid using neat supercritical carbon dioxide or a supercritical carbon dioxide mixture extraction to produce vitreoretinal silicone tamponades. The subject process is an economical, highly effective, reproducible, contaminant-free method by which unreacted relatively low molecular weight cyclic siloxanes and oligomers are removed from relatively high molecular weight silicone oil or fluid.

Description

  • Priority is hereby claimed in the present nonprovisional application to Provisional Application Serial No. 60/366,696 filed Mar. 21, 2002, in accordance with 37 CFR 1.78(a)(4).[0001]
  • FIELD OF THE INVENTION
  • The present invention relates to a novel, highly effective method to purify vitreofluid silicone oils or fluids using supercritical fluid extraction. More particularly, the present invention relates to a method for purifying vitreofluid silicone oils or fluids that is contaminant-free and, in most cases, does not require the disposal of organic solvents. [0002]
  • BACKGROUND OF THE INVENTION
  • Ocular tamponades are vitreous substitutes that are used to reposition the retina of an eye in instances where a reattachment is not achievable by natural healing or by laser coagulation. The purpose of a vitreous substitute is to provide long-term tamponade of the retina, i.e., exhibit an ideal pressure (force/area) to position and maintain the retina in place. Current commercially used tamponades include perfluorocarbon-liquids, balanced salt solutions, silicone oil or fluid and gases, such as air, sulfur hexafluoride (SF[0003] 6) and perfluorocarbons (PFCs). Silicone oil or fluid is the preferred tamponade in cases of severe retina detachment, where the tamponade is used six months or longer.
  • Silicone oil or fluid is prepared by a ring-opening polymerization of strained cyclic silicones. The final product consists of relatively high molecular weight silicone fluid and unreacted relatively low molecular weight cyclic siloxanes and oligomers. The unreacted relatively low molecular weight cyclics and oligomers are cytotoxic and have been implicated in an undesirable emulsification phenomenon that sometimes occurs in silicone-based fluids. Accordingly, the unreacted relatively low molecular weight cyclics and oligomers must be removed from the silicone fluid product to be useful as an ocular tamponade. The preferred current method of purifying relatively high molecular weight silicone oil, or silicone fluid, involves the use of a lengthy solvent extraction process whereby the silicone fluid is slowly added to a non-solvent, such as acetone, and allowed to separate. The unreacted low molecular weight cyclics and oligomers are soluble in the non-solvent or acetone phase. The unreacted low molecular weight cyclics and oligomers are thus removed with the non-solvent or acetone phase upon separation thereof from the high molecular weight silicone fluid. Once separated, the non-solvent phase with the low molecular weight cyclics and oligomers becomes an undesirable waste product of the purification method and requires disposal. Likewise, following purification, controls are necessary to ensure the final silicone oil or fluid product is free of non-solvent contamination. [0004]
  • Because of the noted shortcomings of the current, preferred method of silicone fluid purification to remove cytotoxic impurities therefrom, there is a need for a purification method that is effective, less time consuming, eliminates the potential for non-solvent residual contamination and lessens or eliminates non-solvent waste production. [0005]
  • SUMMARY OF THE INVENTION
  • The present invention is an economical, highly effective process for the purification of relatively high molecular weight vitreofluid silicone oils or fluids using carbon dioxide supercritical fluid (SCF) extraction. A fluid with its temperature and pressure simultaneously higher than its critical temperature and pressure is in the supercritical state. The most ubiquitous SCF, carbon dioxide, is a gas at ambient conditions. In a supercritical state, it is essentially a compressed, high density fluid. Carbon dioxide is relatively innocuous, economical, and non-reactive under most operating conditions. The density, solvent power or selectivity of a SCF is easily altered with relatively small changes in pressure or by addition of small amounts of an organic solvent. The change in carbon dioxide density with pressure at 35 degrees Celsius does not increase linearly with increasing pressure. Small changes in pressure produce large changes in density when operating close to the critical point. For example, at 83 bar the compressibility of carbon dioxide is high. At 700 bar, the compressibility of carbon dioxide is low. The advantages of using carbon dioxide SCF for purification of vitreofluid silicone oils or fluids is that it is economical, reproducible, contaminant-free and in most cases does not require the disposal of non-solvent waste. Carbon dioxide SCF extraction in accordance with the present invention has solvating powers comparable to those of the non-solvents currently used in the purification of relatively high molecular weight silicone oil or fluid. [0006]
  • Accordingly, it is an object of the present invention to provide a process for the purification of relatively high molecular weight silicone fluid. [0007]
  • Another object of the present invention is to provide a process for the purification of relatively high molecular weight silicone fluid that is economical. [0008]
  • Another object of the present invention is to provide a process for the purification of relatively high molecular weight silicone fluid that is reproducible. [0009]
  • Another object of the present invention is to provide a process for the purification of relatively high molecular weight silicone fluid that is contaminant-free. [0010]
  • Another object of the present invention is to provide a process for the purification of relatively high molecular weight silicone fluid for use as an ocular tamponade. [0011]
  • Still another object of the present invention is to provide a process for the purification of a relatively high molecular weight silicone fluid that lessens or eliminates the need for non-solvent waste disposal. [0012]
  • A further object of the present invention is to eliminate low molecular weight silicone oligomers and cyclics from relatively high molecular weight silicone fluid in order to lessen or eliminate emulsification of the relatively high molecular weight silicone fluid in ocular tamponade uses. [0013]
  • These and other objectives and advantages of the present invention, some of which are specifically described and others that are not, will become apparent from the detailed description and claims that follow. [0014]
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention relates to a novel process for the purification of relatively high molecular weight silicone oil or fluid for use as an ocular tamponade. The purification process of the present invention is a novel, economical, highly effective, reproducible, contaminant-free process for removing relatively low molecular weight cyclics and oligomers from relatively high molecular weight silicone oil or fluid. The subject process utilizes supercritical carbon dioxide (scCO[0015] 2) fluid extraction to purify silicone fluid for use as an ocular tamponade. The supercritical carbon dioxide fluid has solvating powers comparable to those of organic solvents. Likewise, the solvating power of the supercritical carbon dioxide fluid is adjustable through variations in pressure and temperature, or by adding modifiers to form a mixture as discussed in more detail below. Examples of suitable modifiers include but are not limited to methanol, isopropanol, acetonitrile and acetone.
  • Using the process of the present invention, a 5,000 cps silicone oil tamponade was purified using supercritical carbon dioxide fluid extraction. The conditions of the supercritical carbon dioxide fluid extraction consisted of carbon dioxide at a pressure of approximately 3,000 pounds per square inch (psi), a temperature of approximately 55 degrees Celsius and a flow rate of approximately 52 gm per minute. Using said conditions, the relatively low molecular weight cyclics and oligomers were removed from the silicone fluid to a level below size exclusion chromatography (SEC) detection limits. More particularly, SEC showed the removal of relatively low molecular weight cyclics and oligomers with no change in the silicone fluid peak height. Similar results were obtained by extracting with supercritical carbon dioxide fluid containing 10 percent acetone. [0016]
  • The silicone oil tamponade purification process of the present invention is described in still greater detail in the examples that follow. [0017]
  • EXAMPLE 1
  • Extraction of Silicone Oil with Supercritical Carbon Dioxide Fluid: [0018]
  • Polydimethylsiloxane (21.01 gm) sample was loaded into a 0.7 inch tube. The loaded tube was then placed in a 3.0 inch cup. The 3.0 inch cup with the sample was placed into an extraction vessel and a lid with a ¼ inch pipe attachment was placed on the extraction vessel. The lid was placed such that the ¼ inch pipe attachment was inside the 0.7 inch tube. The extraction vessel was then pressurized to 140 bar with carbon dioxide using bottom to top flow. The extraction vessel temperature was approximately 55 degrees Celsius in an oil bath of approximately 102 degrees Celsius. A flow of 26 gm per minute carbon dioxide was begun in the extraction vessel from the top to the bottom. After one hour and 37 minutes, an increased flow rate of 52 gm per minute carbon dioxide was begun. After one hour and fifty-three minutes, the extraction vessel pressure was increased to 207 bar. After a total of four hours, the flow of carbon dioxide was discontinued and the extraction vessel was depressurized. [0019]
    Initial weights: Extraction vessel = 231.46 gm
    Cup = 217.73 gm
    Lid and pipe = 339.64 gm
    Tube =  60.96 gm
    Sample =  21.01 gm
  • [0020]
    TABLE 1
    SCF Extraction Process Conditions Summary for Example 1:
    Initial Conditions:
    CO2 rate: approximately 55 gm/minute
    driven by cylinder pressure up to
    55-60 bars
    Vessel pressure: 140 bars
    Vessel temperature:  55 degrees Celsius
    Oil bath temperature: 102 degrees Celsius
    Process Conditions:
    CO2 rate: approximately 26 gm/minute
    Vessel pressure: 140 bars
    Flow time:  90 minutes
    CO2 rate: approximately 52 gm/minute
    Vessel pressure: 140 bars
    Flow time:  16 minutes
    CO2 rate: approximately 52 gm/minute
    Vessel pressure: 207 bars
    Flow time:  67 minutes
  • EXAMPLE 2
  • Extraction of Silicone Oil with Supercritical Carbon Dioxide Fluid and Acetone: [0021]
  • Polydimethylsiloxane (21.01 gm) sample was loaded into a 0.7 inch tube. The loaded tube was then placed in a 3.0 inch cup. The 3.0 inch cup with the sample was then placed in an extraction vessel and a lid with a ¼ inch pipe attachment was placed on the extraction vessel. The lid was placed such that the ¼ inch pipe attachment was inside the 0.7 inch tube. The extraction vessel was then pressurized to 140 bar with carbon dioxide using bottom to top flow. The extraction vessel temperature was approximately 55 degrees Celsius in an oil bath of approximately 102 degrees Celsius. A flow of 6 gm per minute acetone and 20 gm per minute carbon dioxide was begun in the extraction vessel from the top to the bottom. After one and a half hours, 404.5 gm of acetone had been used. The flow of acetone was then discontinued while the flow of carbon dioxide was continued for an additional two and a half hours. The flow of carbon dioxide was likewise then discontinued and the extraction vessel was depressurized. [0022]
    TABLE 2
    SCF Extraction Process Conditions Summary for Examnle 2:
    Initial Conditions:
    CO2 rate: approximately 55 gm/minute
    driven by cylinder pressure up to
    55-60 bars
    Vessel pressure: 140 bars
    Vessel temperature:  55 degrees Celsius
    Oil bath temperature: 102 degrees Celsius
    Process Conditions:
    CO2 rate: approximately 20 gm/minute
    Acetone rate:  6 gm/minute
    Pumping time:  90 minutes
    Vessel pressure: 140 bars
    Drying Conditions:
    CO2 rate: approximately 20 gm/minute
    Acetone rate:  0 gm/minute
    Flow time: 150 minutes
  • [0023]
    CHART 1
    Comparative Results for Silicone Oil
    Extracted by Various Processes
    Viscosity at Surface
    21° C. tension, Interfacial tension,
    Sample cps (mPa-s) dynes/cm (mN/m) dynes/cm (mN/m)
    Silicone oil 5,700 24.2 Could not be
    unextracted measured
    Acetone extracted 6,800 25.4 Difficult to measure
    silicone oil due to closeness of
    oil/water phase
    densities
    sc-CO2/ 6,890 25.4 30 with distinct
    acetone phases
    extracted silicone
    oil
    sc-CO2 8,000 25.4 32 with distinct
    extracted phases
    silicone oil
  • Silicone oil or fluid ocular tamponades purified using the purification process of the present invention are used as customary in the field of ophthalmology. For example, in a surgical vitreoretinal procedure, the silicone oil or fluid ocular tamponade purified in accordance with the process of the present invention is placed and maintained in the posterior segment of the eye for the desired period of time prior to the removal thereof. [0024]
  • While there is shown and described herein a process for the purification of silicone oil or fluid for use as an ocular tamponade using supercritical carbon dioxide fluid or a supercritical carbon dioxide mixture fluid, it will be manifest to those skilled in the art that various modifications may be made without departing from the spirit and scope of the underlying inventive concept and that the same is not limited to particular processes herein described except insofar as indicated by the scope of the appended claims. [0025]

Claims (16)

We claim:
1. A process for the purification of silicone oil or fluid for use as an ocular tamponade comprising:
performing a supercritical carbon dioxide extraction of said silicone oil or fluid to remove cyclic and oligomeric impurities.
2. A process for the purification of silicone oil or fluid for use as an ocular tamponade comprising:
performing a supercritical carbon dioxide mixture extraction of said silicone oil or fluid to remove cyclic and oligomeric impurities.
3. The process of claim 1 wherein said extraction is conducted at a pressure of approximately 3000 psi, a temperature of approximately 55 degrees Celsius and a carbon dioxide flow rate of approximately 52 gm/minute.
4. The process of claim 2 wherein said extraction is conducted at a pressure of approximately 3000 psi, a temperature of approximately 55 degrees Celsius and a carbon dioxide mixture flow rate of approximately 52 gm/minute.
5. The process of claim 1 wherein said extraction is conducted at a carbon dioxide flow rate of approximately 20 to 26 gm/minute and a flow time of approximately 90 minutes.
6. The process of claim 2 wherein said extraction is conducted at a carbon dioxide mixture flow rate of approximately 20 to 26 gm/minute and a flow time of approximately 90 minutes.
7. The process of claim 2 wherein said carbon dioxide mixture comprises approximately 90 percent carbon dioxide and approximately 10 percent acetone.
8. The process of claim 2 wherein said carbon dioxide mixture comprises carbon dioxide and a modifier.
9. The process of claim 2 wherein said carbon dioxide mixture comprises carbon dioxide and acetone or acetonitrile.
10. The process of claim 2 wherein said carbon dioxide mixture comprises carbon dioxide and methanol.
11. The process of claim 2 wherein said carbon dioxide mixture comprises carbon dioxide and isopropanol.
12. The process of claim 2 wherein said carbon dioxide mixture comprises approximately 90 percent carbon dioxide and approximately 10 percent methanol.
13. The process of claim 2 wherein said carbon dioxide mixture comprises approximately 90 percent carbon dioxide and approximately 10 percent isopropanol.
14. A silixone oil or fluid ophthalmic tamponade produced using the process of claim 1 or 2.
15. A method of using the silicone oil or fluid ophthalmic tamponade of claim 14 in an ophthalmic surgical procedure comprising:
creating an incision into a posterior chamber of an eye;
positioning damaged retinal tissue within the eye; and
filling said posterior chamber of the eye with said silicone oil.
16. A method of using the silicone oil ophthalmic tamponade of claim 14 in an ophthalmic surgical procedure comprising:
creating an incision into a posterior chamber of an eye; and
filling said posterior chamber of the eye with said silicone oil or fluid.
US10/165,834 2002-03-21 2002-06-07 Supercritical fluid extraction of vitreoretinal silicone tamponades Abandoned US20030181749A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US10/165,834 US20030181749A1 (en) 2002-03-21 2002-06-07 Supercritical fluid extraction of vitreoretinal silicone tamponades
DE60323471T DE60323471D1 (en) 2002-03-21 2003-03-20 EXTRACTION OF VITREORETINAL SILICONTAMPONADES WITH SUPERCRITICAL LIQUIDS
ES03714340T ES2312759T3 (en) 2002-03-21 2003-03-20 EXTRACTION WITH SUPERCRITICAL FLUID OF VITREORETINAL SILICONE COUPLINGS.
AU2003218343A AU2003218343A1 (en) 2002-03-21 2003-03-20 Supercritical fluid extraction of vitreoretinal silicone tamponades
PCT/US2003/008902 WO2003080713A1 (en) 2002-03-21 2003-03-20 Supercritical fluid extraction of vitreoretinal silicone tamponades
EP03714340A EP1487903B1 (en) 2002-03-21 2003-03-20 Supercritical fluid extraction of vitreoretinal silicone tamponades
ARP030100992 AR039095A1 (en) 2002-06-07 2003-03-21 SUPERCRITICAL FLUID EXTRACTION OF VITREORETINAL SILICONE TAMPONS
US10/801,741 US7276619B2 (en) 2002-03-21 2004-03-16 Vitreoretinal silicone tamponades made by supercritical fluid extraction

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36669602P 2002-03-21 2002-03-21
US10/165,834 US20030181749A1 (en) 2002-03-21 2002-06-07 Supercritical fluid extraction of vitreoretinal silicone tamponades

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/801,741 Division US7276619B2 (en) 2002-03-21 2004-03-16 Vitreoretinal silicone tamponades made by supercritical fluid extraction

Publications (1)

Publication Number Publication Date
US20030181749A1 true US20030181749A1 (en) 2003-09-25

Family

ID=28044368

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/165,834 Abandoned US20030181749A1 (en) 2002-03-21 2002-06-07 Supercritical fluid extraction of vitreoretinal silicone tamponades
US10/801,741 Expired - Fee Related US7276619B2 (en) 2002-03-21 2004-03-16 Vitreoretinal silicone tamponades made by supercritical fluid extraction

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/801,741 Expired - Fee Related US7276619B2 (en) 2002-03-21 2004-03-16 Vitreoretinal silicone tamponades made by supercritical fluid extraction

Country Status (6)

Country Link
US (2) US20030181749A1 (en)
EP (1) EP1487903B1 (en)
AU (1) AU2003218343A1 (en)
DE (1) DE60323471D1 (en)
ES (1) ES2312759T3 (en)
WO (1) WO2003080713A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013520291A (en) * 2010-02-23 2013-06-06 パワーヴィジョン・インコーポレーテッド Liquid for accommodation type intraocular lens

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030060878A1 (en) * 2001-08-31 2003-03-27 Shadduck John H. Intraocular lens system and method for power adjustment
US8048155B2 (en) 2002-02-02 2011-11-01 Powervision, Inc. Intraocular implant devices
US7217288B2 (en) 2002-12-12 2007-05-15 Powervision, Inc. Accommodating intraocular lens having peripherally actuated deflectable surface and method
US10835373B2 (en) 2002-12-12 2020-11-17 Alcon Inc. Accommodating intraocular lenses and methods of use
US8328869B2 (en) 2002-12-12 2012-12-11 Powervision, Inc. Accommodating intraocular lenses and methods of use
US8361145B2 (en) 2002-12-12 2013-01-29 Powervision, Inc. Accommodating intraocular lens system having circumferential haptic support and method
CA2517576A1 (en) 2003-03-06 2004-09-23 John H. Shadduck Adaptive optic lens and method of making
US7368589B2 (en) * 2003-10-31 2008-05-06 Johnson & Johnson Vision Care, Inc. Purification of silicone containing compounds by supercritical fluid extraction
US9872763B2 (en) 2004-10-22 2018-01-23 Powervision, Inc. Accommodating intraocular lenses
KR101261390B1 (en) 2005-04-06 2013-05-09 다우 코닝 코포레이션 Organosiloxane compositions
US8668734B2 (en) 2010-07-09 2014-03-11 Powervision, Inc. Intraocular lens delivery devices and methods of use
US8968396B2 (en) 2007-07-23 2015-03-03 Powervision, Inc. Intraocular lens delivery systems and methods of use
EP2178462B1 (en) 2007-07-23 2014-04-02 PowerVision, Inc. Post-implant lens power modification
JP5346022B2 (en) 2007-07-23 2013-11-20 パワーヴィジョン・インコーポレーテッド Accommodating intraocular lens and method of use
WO2009015240A2 (en) 2007-07-23 2009-01-29 Powervision, Inc. Lens delivery system
US8314927B2 (en) 2007-07-23 2012-11-20 Powervision, Inc. Systems and methods for testing intraocular lenses
US10299913B2 (en) 2009-01-09 2019-05-28 Powervision, Inc. Accommodating intraocular lenses and methods of use
GB0905205D0 (en) 2009-03-26 2009-05-13 Dow Corning Preparation of organosiloxane polymer
GB0905204D0 (en) 2009-03-26 2009-05-13 Dow Corning Preparation of organosiloxane polymers
EP2473138A4 (en) * 2009-08-31 2017-08-16 PowerVision, Inc. Lens capsule size estimation
EP2563275A4 (en) 2010-04-27 2017-11-22 Lensgen, Inc Accommodating intraocular lens device
JP6071995B2 (en) 2011-03-24 2017-02-01 パワーヴィジョン・インコーポレーテッド Intraocular lens loading system and method of use
US10433949B2 (en) 2011-11-08 2019-10-08 Powervision, Inc. Accommodating intraocular lenses
EP3785668A1 (en) 2013-03-15 2021-03-03 Alcon Inc. Intraocular lens storage and loading devices and methods of use
CN106413634B (en) 2013-11-01 2019-03-05 雷恩斯根公司 Double component modulability intraocular lens equipment
WO2015066502A1 (en) 2013-11-01 2015-05-07 Thomas Silvestrini Accomodating intraocular lens device
US10004596B2 (en) 2014-07-31 2018-06-26 Lensgen, Inc. Accommodating intraocular lens device
US10647831B2 (en) 2014-09-23 2020-05-12 LensGens, Inc. Polymeric material for accommodating intraocular lenses
AU2016275073B2 (en) 2015-06-10 2021-02-25 Alcon Inc. Intraocular lens materials and components
EP3884905A1 (en) 2015-11-06 2021-09-29 Alcon Inc. Ccommodating intraocular lenses
AU2016362384B2 (en) 2015-12-01 2021-10-07 Lensgen, Inc. Accommodating intraocular lens device
WO2017205811A1 (en) * 2016-05-27 2017-11-30 Thomas Silvestrini Lens oil having a narrow molecular weight distribution for intraocular lens devices
AU2020360242A1 (en) 2019-10-04 2022-04-28 Alcon Inc. Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340614A (en) * 1993-02-11 1994-08-23 Minnesota Mining And Manufacturing Company Methods of polymer impregnation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02302437A (en) * 1989-05-17 1990-12-14 Shin Etsu Chem Co Ltd Method for purifying polyorganosilsesquioxane polymer
JPH03202102A (en) * 1989-12-28 1991-09-03 Toray Dow Corning Silicone Co Ltd Method for reducing amount of siloxane oligomer in organopolysiloxane molded product
JPH06107796A (en) * 1991-08-01 1994-04-19 Chlorine Eng Corp Ltd Purification of modified silicone oil
JPH0543699A (en) * 1991-08-15 1993-02-23 Chlorine Eng Corp Ltd Method for purifying silicone oil
DE4220882C2 (en) * 1992-06-25 1995-10-12 Adatomed Pharma Chiron Use of liquid perfluorocarbons for vitreous tamponade
US5336487A (en) * 1993-03-05 1994-08-09 Refojo Miguel F Method of treating eye disorders with silicon/fluorosilicone copolymer oil
BR9507054A (en) * 1994-01-31 1997-09-16 Bausch & Lomb Method for producing an optically transparent lens
JPH09150002A (en) * 1995-11-29 1997-06-10 Shin Etsu Chem Co Ltd Refining method for silicone oil
ID18055A (en) 1996-08-21 1998-02-26 Novartis Ag METHOD FOR TREATING MOLD GOODS
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
US6294194B1 (en) * 1997-10-14 2001-09-25 Boehringer Ingelheim Pharmaceuticals, Inc. Method for extraction and reaction using supercritical fluids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340614A (en) * 1993-02-11 1994-08-23 Minnesota Mining And Manufacturing Company Methods of polymer impregnation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013520291A (en) * 2010-02-23 2013-06-06 パワーヴィジョン・インコーポレーテッド Liquid for accommodation type intraocular lens

Also Published As

Publication number Publication date
EP1487903B1 (en) 2008-09-10
WO2003080713A1 (en) 2003-10-02
US7276619B2 (en) 2007-10-02
EP1487903A1 (en) 2004-12-22
US20040176628A1 (en) 2004-09-09
DE60323471D1 (en) 2008-10-23
AU2003218343A1 (en) 2003-10-08
ES2312759T3 (en) 2009-03-01

Similar Documents

Publication Publication Date Title
US7276619B2 (en) Vitreoretinal silicone tamponades made by supercritical fluid extraction
US6368359B1 (en) Process for stabilization of dry cleaning solutions
JPH03202102A (en) Method for reducing amount of siloxane oligomer in organopolysiloxane molded product
KR20030067478A (en) Methods for extraction and reaction using supercritical fluids
KR970701749A (en) PROCESS FOR INCREASING THE MOLECULAR WEIGHT OF POLYAMIDES AND OTHER CONDENSATION POLYMERS
KR101584727B1 (en) Manufacturing method of high purity 1,2-hexanediol
CN113698606A (en) Preparation method of vinyl silicone oil with low content of cyclic bodies
CN115612104B (en) Production process of electronic grade 107 with low ring body content
US5312947A (en) Siloxane purification
CN110358090A (en) A kind of method for preparing polysiloxane by catalysis of supported phosphazene catalyst
WO2004026320A1 (en) Vitreoretinal tamponades based on fluorosilicone fluids
JPH0674296B2 (en) Rubber purification method
EP3974044A1 (en) Process for the aqueous extraction of biosurfactants from corn steep liquor
CN105542171B (en) A kind of alcohol-soluble lubricant and preparation method thereof
WO2015031085A1 (en) Catalyst for synthesis of siloxanes
CA2378321A1 (en) Molding of a polyalkylene glycol terephtalate and an aromatic ester
US20020000009A1 (en) Process for stabilization of dry cleaning solutions
JP3622264B2 (en) Method for stabilizing N-vinylamide
JPH06279401A (en) Method of purifying n-methyl-2-pyrrolidone
CN114768284A (en) Purification method of silicone oil for intraocular tamponade
RU2184729C1 (en) Method of removing organic impurities from tocopherol prepared by chemical synthesis
KR970010947A (en) Freezing point cooling process plum wine manufacturing method
RU2085147C1 (en) Material for filling eye retina
TWI549994B (en) A crossed siloxane macromolecule comprising polymerization functional groups and hydrophilic groups and method for manufacturing the crossed siloxane macromolecule
JPH01129022A (en) Reduction of cyclic oligomer ether content in tetrahydrofuran copolymer

Legal Events

Date Code Title Description
AS Assignment

Owner name: BAUSCH & LOMB INCORPORATED, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KUNZLER, JAY E.;SALAMONE, JOSEPH C.;JANI, DHARMENDRA;AND OTHERS;REEL/FRAME:013192/0774

Effective date: 20020625

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载